Noble Prize, one of the most esteemed prizes of the world-is awarded by a Swedish council. This prize is awarded in diverse Fields, medicine being one of them. The council Picks major breakthroughs or contributions in the respective fields from around the world to confer this honour. This year’s noble prize for Medicine or Physiology was announced yesterday. According to the reports this prize will be shared between James P. Allison of the United States and Tasuku Honjo of Japan for their marvellous work on cancer medicine.
Working separately in different parts of the world, both Dr Allison and Dr Honjo have found out a way of making the immune system to Attack the cancerous cells. A new class of drugs have evolved as a result of these tests. These drugs belong to a class called ‘checkpoint inhibitors’.
They work by bringing one’s immune system to Attack the cancerous cells. This process of treatment using checkpoint inhibitors is called immunotherapy. But The downside of these drugs is that they are very expensive and may sometimes cause dangerous side effects.
Some of the different kinds of cancers that can be treated with checkpoint inhibitors are:-
Aggressive skin-care etc.
Dr Honjo, Who is 76 Years-old did his Noble winning work from the Kyoto University of which he is also a lifetime professor. On the other hand, Dr Allison, Who is 70 years old did his research from the University of California at Berkeley and Memorial Sloan Kettering Cancer Center in New York. Both of them worked alone in a common field to find a cure for a disease that millions suffer from in this day and age. They will jointly win and share the Noble Prize for Medicine or Physiology.
There are different types of cancers that people suffer from all around the world. But there are very few ways-if treatments for this disease. In such a Scenario, this discovery made by the two soon-to-be Noble Laureates is like a ray of new hope for the millions of people suffering from cancer. And to give them recognition for their work is something they deserve with full rights. I hope their works inspire the generations of new researchers to come to work better in their respective fields and contribute and add something more for the betterment of the humankind.